Insider trades
David Lebwohl, Chief Officer of Intellia Therapeutics NTLA, has filed 0 purchases and 4 sales on the open market. Over the past 12 months that comes to a net sale of $109.6K. The latest trade was on 03/01.
David Lebwohl
EVP, Chief Medical Officer
- Company
- Intellia Therapeutics NTLA
- First filing
- 23/01/04
- Trades
- 18 trades
- Buys / sales
- 0 / 4
- 12-month net buying
- −$109.6K
- Last trade
- 03/01
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 01/05 | 01/07 | 11,903 sh | $9.21 | $109,626.63 | −8.9% | |
| Open-market sale | 25/01/03 | 25/01/07 | 9,557 sh | $12.18 | $116,404.26 | −9.8% | |
| Open-market sale | 24/01/03 | 24/01/05 | 5,843 sh | $29.46 | $172,134.78 | −9.7% | |
| Open-market sale | 23/01/04 | 23/01/06 | 2,574 sh | $37.21 | $95,778.54 | −9.1% |